More NewsOrexigen Therapeutics Announces Departure of CFO

Orexigen Therapeutics Announces Departure of CFO

Orexigen Therapeutics, a biopharmaceutical company focused on the treatment of obesity, has announced the upcoming resignation of Graham Cooper, senior vice president (SVP), finance, chief financial officer (CFO) and treasurer. Cooper, who has been with Orexigen for over four years, has decided to leave for personal reasons. He will remain in his current role at Orexigen until the reporting of the company’s year-end results and the filing of its annual report on Form 10-K with the SEC for the year ended 31 December 2010.

The company will name Jay Hagan, SVP, corporate development and strategy, as acting-CFO and transition the financial operation responsibilities to him. Hagan joined the company in May 2009 after 10 years at Amgen. He was instrumental in helping Orexigen secure the partnership with Takeda Pharmaceuticals North America for Contrave (naltrexone Sustained Release (SR)/bupropion SR). Since joining the company to lead corporate development in 2009, Hagan has taken on increased responsibility, leading the corporate communications and technical operations functions at Orexigen.

Steve Moglia, senior director of financial reporting and controller, and Judy Fox, assistant controller, will continue to play key leadership roles in Orexigen’s finance department. Moglia joined Orexigen in 2008 and is responsible for managing all financial reporting, Sarbanes-Oxley compliance, stock administration and tax compliance activities. Prior to joining Orexigen, he served as the director of SEC reporting and compliance at Biosite. Moglia is a certified public accountant (CPA) (inactive) in California.

Fox joined Orexigen in 2007 and is responsible for accounting, financial management, 401(k) and other accounting related administrative functions. Prior to joining Orexigen, she served as assistant controller at Diversa Corporation. Fox received her MBA from California State University, San Marcos.

Related Articles

Infosys Finacle to power Santander UK’s international cash management system

More News Infosys Finacle to power Santander UK’s international cash management system

3w The Global Treasurer
Preparing for GDPR? Here’s four things to consider

More News Preparing for GDPR? Here’s four things to consider

4m Elliott Wiseman
Cash flow in focus for investors

Cash Management Cash flow in focus for investors

5m Conor Deegan
Treasury TV: Karen Pugsley, Domino's Pizza Group

More News Treasury TV: Karen Pugsley, Domino's Pizza Group

5m Victoria Beckett
Treasury TV: Yeng Butler compares US and European MMF reforms

Compliance Treasury TV: Yeng Butler compares US and European MMF reforms

5m Victoria Beckett
Treasury TV: Tim de Knegt, The Port of Rotterdam

10 Minutes With The Treasury Treasury TV: Tim de Knegt, The Port of Rotterdam

5m Victoria Beckett
Banks are selling clients short with short dated cash deposit U-turns

Banking Banks are selling clients short with short dated cash deposit U-turns

5m Victoria Beckett
What does sterling’s Brexit boost mean for UK manufacturers?

More News What does sterling’s Brexit boost mean for UK manufacturers?

6m Tasja Botha